Lung and Bronchus Cancer Archives - Together4Cancer Compass

Patients

HCPs

Home

Categories

Quantifying intrafractional colon tumor motion on 1.5 T MR-linac cine-MRI and applying anisotropic residual-motion margins for SBRT.

Post category:Digestive (CRC, Stomach) System
Reading time:2 mins read

Study type and population Prospective, single‑center, observational cross‑sectional study in 24 patients with unre...

Continue Reading

Effectiveness and Safety of Percutaneous Image-Guided Lung Biopsies: Analysis of 27559 Procedures from the German Society for Interventional Radiology and Minimally Invasive Therapy Registry.

Post category:Respiratory (Lung, Bronchus) System
Reading time:2 mins read

Title: Effectiveness and Safety of Percutaneous Image-Guided Lung Biopsies: Analysis of 27,559 Procedures from the DeGIR...

Continue Reading

Coexposure to asbestos, mineral wool, crystalline silica and refractory ceramic fibres and risk of lung cancer and mesothelioma.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

This study evaluated whether coexposure to other mineral particles modifies asbestos-related cancer risk in a cohort of...

Continue Reading

Integrative fragmentomic and mutational signature profile of plasma cfDNA for early lung cancer detection.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

Study type and population - Large case–control study developing a blood-based assay for lung cancer detection. - 1...

Continue Reading

Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

This study used multi-omics profiling (proteomics, phosphoproteomics, genomics and transcriptomics) in 240 patients with...

Continue Reading

Neuropsychiatric adverse events associated with lorlatinib in ALK-positive NSCLC.

Post category:Respiratory (Lung, Bronchus) System
Reading time:1 min read

This study analyzed post‑marketing safety data to better define the neuropsychiatric adverse event profile of lorlatin...

Continue Reading